Fundamentals of drug development

著者

    • Barrett, Jeffrey S.

書誌事項

Fundamentals of drug development

Jeffrey S. Barrett

Wiley, c2022

  • : hbk

電子リソースにアクセスする 全1

大学図書館所蔵 件 / 1

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Fundamentals of DRUG DEVELOPMENT Enables readers to understand the process of pharmaceutical research, its regulatory basis, and how it fits into the global healthcare environment This book discusses how to conduct pharmaceutical research and the context for how the industry fits into global healthcare. Holistically, the well-qualified author helps readers and students of drug development appreciate the time and expense of the process. Specifically, the work identifies the emerging trends shaping the future of drug development, along with important related topics like generic drugs, data sharing, and collaboration. To aid in seamless reader comprehension, the book includes a glossary of terms and a self-assessment quiz for each chapter at the end. PowerPoint slides are also available as an online ancillary for adopting professors. Sample topics covered in the book include: Drug development and its phases Decision-making processes, drug development milestones, and compound progression metrics The various disciplines involved along with an assessment of the complexity and risks associated across the stages of development Differences in the nature and scope of development programs due to the therapeutic area of interest Associated costs and resources required Graduate students and professors teaching courses in drug development, drug discovery, pharmaceuticals, medicinal chemistry, and drug synthesis will be able to use this book as a complete resource for understanding all the complexities and nuances involved in the drug development process.

目次

Preface and Introduction Chapter 1: The History of Drug Development Chapter 2: The Modern Pharmaceutical Industry: Big and Small Pharma, Biotechnology Companies, and Generic Drug Makers Chapter 3: Legal Considerations, Intellectual Property, Patents and Patent Protection Chapter 4: The Global Regulatory Landscape Chapter 5: Phases of Drug Development: Old and New Paradigms Chapter 6: Discovery / Preclinical Chapter 7: Phase I Chapter 8: Phase II Chapter 9: Phase III Chapter 10: Phase IV, Special Populations and Post Marketing Commitments Chapter 11: Role and Function of Project Teams Chapter 12: Compound Progression and Go / No Go Criteria Chapter 13: Regulatory Milestones and the Submission Process Chapter 14: Life Cycle Management Chapter 15: Formulation Development Chapter 16: Chemistry and Manufacturing (CMC) Chapter 17: Health Economics and the Healthcare Industry Chapter 18: Current State of Affairs: Attrition Rates and Evolving Corporate Strategies Chapter 19: Medical Devices Chapter 20: Distribution and the Supply Chain Chapter 21: Sales, Marketing and Advertising Chapter 22: Generic Drugs and the Generic Industry Chapter 23: The Generic Approval Process Chapter 24: Data Sharing and Collaboration Chapter 25: The Future of the Pharmaceutical Industry Glossary Chapter Self-Assessments and Quiz

「Nielsen BookData」 より

詳細情報

ページトップへ